Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $67.94 million. The enterprise value is -$99.60 million.

Market Cap	67.94M
Enterprise Value	-99.60M

Important Dates

The next confirmed earnings date is Monday, March 31, 2025, before market open.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 48.88 million shares outstanding. The number of shares has increased by 20.93% in one year.

Current Share Class	48.88M
Shares Outstanding	48.88M
Shares Change (YoY)	+20.93%
Shares Change (QoQ)	+1.34%
Owned by Insiders (%)	3.10%
Owned by Institutions (%)	66.20%
Float	41.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.43
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-167.30

Financial Efficiency

Return on equity (ROE) is -56.46% and return on invested capital (ROIC) is -36.32%.

Return on Equity (ROE)	-56.46%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-36.32%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.12M
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.62% in the last 52 weeks. The beta is 2.39, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	2.39
52-Week Price Change	-91.62%
50-Day Moving Average	2.09
200-Day Moving Average	4.15
Relative Strength Index (RSI)	30.41
Average Volume (20 Days)	771,750

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-125.14M
Pretax Income	-89.98M
Net Income	-115.86M
EBITDA	-123.48M
EBIT	-125.14M
Earnings Per Share (EPS)	-$2.34

Full Income Statement

Balance Sheet

The company has $183.01 million in cash and $15.22 million in debt, giving a net cash position of $167.79 million or $3.43 per share.

Cash & Cash Equivalents	183.01M
Total Debt	15.22M
Net Cash	167.79M
Net Cash Per Share	$3.43
Equity (Book Value)	174.24M
Book Value Per Share	3.57
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.93%
Shareholder Yield	n/a
Earnings Yield	-169.93%
FCF Yield	n/a

Analyst Forecast

The average price target for Cabaletta Bio is $26.13, which is 1,779.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.13
Price Target Difference	1,779.86%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-12.01%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a